GEMCAD-REVEAL STUDY - Circulating Tumor DNA as a Predictor of Relapse in Patients With Locally Advanced Rectal Cancer.
Clinical trial NCT05674422 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05674422
- Sponsor
- Grupo Espanol Multidisciplinario del Cancer Digestivo
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-05-26
- Primary completion
- 2025-04-26
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.